Bone Marrow Transplantation News

ORLANDO — Higher total body irradiation dose appeared associated with significantly higher risk for nonrelapse mortality and overall mortality among patients with non-Hodgkin lymphoma who underwent reduced-intensity conditioning prior to allogeneic hematopoietic stem cell transplantation, according to study results presented at TCT | Transplantation & Cellular Therapy Meetings.

Older hematopoietic stem cell transplant survivors appeared 2.6 times more likely to report severe, nonminor or life-threatening pain than cancer-free siblings, according to results of a prospective study published in Cancer.

Evaluation by a multidisciplinary team clinic prior to hematopoietic stem cell transplantation appeared to reduce transplant-related morbidity and mortality among older adults with blood cancers, according to results of a prospective survey-based study published in Blood Advances.

Usama Gergis, MD, MBA, has been named director of the bone marrow transplant and immune cellular therapy program at Sidney Kimmel Cancer Center at Jefferson.

Eileen Smith, MD, has been appointed chair of the department of hematology and hematopoietic cell transplantation at City of Hope.

Gabriela S. Hobbs, MD, and Oluwatoyosi Adefunke Onwuemene, MD, MS, will participate in the American Society of Hematology-Harold Amos Medical Faculty Development Program.

Myeloablative conditioning prior to allogeneic hematopoietic stem cell transplantation may result in improved survival compared with reduced-intensity conditioning for patients with acute myeloid leukemia with genomic evidence of measurable residual disease, according to results of a randomized phase 3 study published in Journal of Clinical Oncology.

In 1984, a teenage boy was lying in his hospital bed, his body ravaged by acute graft-versus host disease.

The International Society for Stem Cell Research will honor Margaret A. “Peggy” Goodell, PhD, with the Tobias Lecture Award.

Patients who received allogeneic hematopoietic stem cell transplants between 2013 and 2017 demonstrated substantial improvement in survival outcomes and fewer complications than those who underwent transplantation a decade earlier, according to results of a retrospective study published in Annals of Internal Medicine.